WNK1
WNK1 (WNK lysine deficient protein kinase 1) is a serine/threonine protein kinase of the WNK subfamily, also known as PRKWNK1, HSN2, HSAN2 and PPP1R167. It is thought to help regulate blood pressure by controlling sodium and chloride ion transport. Browse Assay Genie's current range of WNK1 research reagents below, or read on for the biology behind the target.
WNK1 is a member of the protein kinase superfamily, in the Ser/Thr protein kinase family and the WNK subfamily. The NCBI Gene summary describes it as a probable key regulator of blood pressure, acting through control of sodium and chloride ion transport. Its name, WNK, refers to the lysine-deficient kinase architecture reflected in the full name, WNK lysine deficient protein kinase 1.
The WNK1 gene produces alternatively spliced transcript variants that encode different isoforms, although the full-length nature of all of them has not yet been determined. One kidney-specific isoform is kinase-defective and acts as a dominant-negative regulator of the longer isoform 1. It associates with isoform 1 and attenuates its kinase activity. In this way it indirectly down-regulates sodium-chloride cotransporter activity. It does not directly inhibit WNK4 and has no direct effect on sodium and chloride ion transport. In the kidney it may play an important role in regulating sodium and potassium balance.
UniProt records WNK1 in the cytoplasm and nucleus, and also in the cytoskeleton at the spindle. HGNC places the gene in the groups of protein phosphatase 1 regulatory subunits, minor histocompatibility antigens and WNK lysine deficient protein kinases. Mutations in the WNK1 gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II, which accounts for the previous names "protein kinase, lysine deficient 1" and "hereditary sensory neuropathy, type II". Orthologs are named Wnk1 in mouse and rat, and a related family member is WNK3.
WNK1 may be a key regulator of blood pressure through its control of sodium and chloride ion transport.
A kidney-specific kinase-defective isoform helps regulate sodium and potassium balance and indirectly lowers sodium-chloride cotransporter activity.
Mutations in the WNK1 gene have been associated with pseudohypoaldosteronism type II, making it relevant to studies of this disorder.
WNK1 mutations are also associated with hereditary sensory neuropathy type II, linking the kinase to sensory nerve disease research.
WNK1 is a serine/threonine kinase that may be a key regulator of blood pressure by controlling sodium and chloride ion transport. In the kidney, a kinase-defective isoform dominantly inhibits the longer isoform 1, and so may help regulate sodium and potassium balance.
WNK1 is also called PRKWNK1, HSN2, HSAN2 and PPP1R167, and was formerly named protein kinase, lysine deficient 1. Alternatively spliced transcripts encode different isoforms, including a kidney-specific kinase-defective form that acts as a dominant-negative regulator of isoform 1.
Mutations in the WNK1 gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Mouse and rat both have a Wnk1 ortholog; check the datasheet of any product for its validated reactivity.
Other WNK subfamily kinases and related targets in ion transport and blood pressure research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9H4A3; product specifications from Assay Genie datasheets.